3-(2-Chloro-ethyl)-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid methoxy-amide

ID: ALA32012

PubChem CID: 44278716

Max Phase: Preclinical

Molecular Formula: C8H9ClN6O3

Molecular Weight: 272.65

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CONC(=O)c1ncn2c(=O)n(CCCl)nnc12

Standard InChI:  InChI=1S/C8H9ClN6O3/c1-18-12-7(16)5-6-11-13-15(3-2-9)8(17)14(6)4-10-5/h4H,2-3H2,1H3,(H,12,16)

Standard InChI Key:  AJZMRYJJXOLYNG-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 18 19  0  0  0  0  0  0  0  0999 V2000
    5.1625   -4.1250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1625   -3.5250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5917   -3.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6875   -3.2250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6792   -4.4292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3667   -3.5000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3667   -4.1542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2417   -3.8250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5875   -4.3042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4042   -2.7625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6792   -5.0292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8125   -2.3167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0167   -4.4667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6792   -2.6000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6167   -1.8125    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0167   -4.5625    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    7.4875   -4.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3042   -1.8125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  2  0
  4  2  1  0
  5  1  1  0
  6  7  1  0
  7  5  1  0
  8  9  2  0
  9  1  1  0
 10  3  1  0
 11  5  2  0
 12 10  2  0
 13  7  1  0
 14 10  1  0
 15 14  1  0
 16 17  1  0
 17 13  1  0
 18 15  1  0
  3  8  1  0
  4  6  2  0
M  END

Associated Targets(non-human)

TLX-5 (157 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 272.65Molecular Weight (Monoisotopic): 272.0425AlogP: -1.18#Rotatable Bonds: 4
Polar Surface Area: 103.41Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 9.87CX Basic pKa: CX LogP: 0.76CX LogD: 0.76
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.55Np Likeness Score: -1.78

References

1. Horspool KR, Stevens MF, Newton CG, Lunt E, Walsh RJ, Pedgrift BL, Baig GU, Lavelle F, Fizames C..  (1990)  Antitumor imidazotetrazines. 20. Preparation of the 8-acid derivative of mitozolomide and its utility in the preparation of active antitumor agents.,  33  (5): [PMID:2329560] [10.1021/jm00167a018]

Source